Office of Human Research Protection Georgia Health Sciences University.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Module N° 4 – ICAO SSP framework
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Quality Management within the Clinical Research Process
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
Chapter 7: Key Process Areas for Level 2: Repeatable - Arvind Kabir Yateesh.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Good Clinical Practice in Research
© Clinical Research Practice Clinical Research Organization and Management 1.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Contractor Management and ISO 14001:2004
Laboratory Personnel Dr/Ehsan Moahmen Rizk.
John Naim, PhD Director Clinical Trials Research Unit
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Quality Assurance/Quality Control Policy
4. Quality Management System (QMS)
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Who’s the Boss? Faculty Advisor or Principal Investigator Supervision versus Student Investigator or Study Coordinator Responsibilities Gwenn Snow, MS,
Presented to President’s Cabinet. INTERNAL CONTROLS are the integration of the activities, plans, attitudes, policies and efforts of the people of an.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
1 DOE IMPLEMENTATION WORKSHOP ASSESSING MY EMS Steven R. Woodbury
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
IDENTITY THEFT. RHONDA L. ANDERSON, RHIA, PRESIDENT ANDERSON HEALTH INFORMATION SYSTEMS, INC.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
The Audit as a Management Tool Vermont State Auditor’s Office – April 2009.
1 Denise K. Thwing, MAS, RN, CCRA March 31, 2010 Version: Final 31-Mar-2010.
How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Programme Performance Criteria. Regulatory Authority Objectives To identify criteria against which the status of each element of the regulatory programme.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Site Monitoring Shirley Frederiksen Donna Harsh.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Revision N° 11ICAO Safety Management Systems (SMS) Course01/01/08 Module N° 9 – SMS operation.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
Responsibilities of Test Facility Management, Study Director, Principal Investigator and Study Personnel G. Jacobs Belgian GLP Monitorate Zagreb, 17 December.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
Responsibilities of Sponsor, Investigator and Monitor
Reportable Events & Other IRB Updates February 2017
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Good Clinical Practice
Regulatory Binder: Maintaining Essential Study Documentation
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Air Traffic Quality Assurance Program
Good Clinical Practice in Research
The Elements of appropriate Internal Controls
Quality Assurance in Clinical Trials
Protocol Approval Criteria
Presentation transcript:

Office of Human Research Protection Georgia Health Sciences University

 Quality Systems approach to ensuring all aspects of research conduct and compliance are addressed

 Old Audit ◦ Review of all records ◦ More of a monitoring visit ◦ Focused on finding errors  New Assessment ◦ Focused on PI oversight and involvement ◦ Looking for trends ◦ Focus on compliance and educating study staff

 Level 1 ◦ Management Controls ◦ Personnel Controls ◦ Facility Controls  Level 2 ◦ Investigational product control ◦ Safety controls ◦ Records, documents and revision controls  Level 3 ◦ Corrective and preventative action controls

FacilityControls Investigational Product Controls Records, Documents, & Revision Controls SafetyControls PersonnelControls Corrective & PreventiveActions ManagementControls

The PI is ultimately responsible for the conduct of the study and must take an active role in ensuring the study is conducted in compliance with all applicable regulations, policies, and laws. Responsibilities include, but are not limited to:  Appropriate delegation of study related tasks  Adequate supervision of the conduct of the research  PI should ensure there are standard operating procedures for all aspects of the study specific to the research site  The PI should provide management oversight and supervision

The PI must ensure:  Education, training, and expertise of investigative staff  Training measures taken when nonconformities are identified  Ongoing training efforts and study-specific training  Personnel involvement and impact on compliance

 External facility ◦ Outside laboratories  Internal facility ◦ Equipment ◦ Space

Systems to control Investigational products (IP) including the areas of:  Receiving  Storing and security measures/ access controls  Dispensing  Overall accountability  Use  Return  Reconciliation  Process for approving personnel

 Adverse event reporting  Medical oversight ◦ Physician involvement in (inclusion/exclusion) ◦ Appropriate or over delegation  Laboratory and specialty testing  Human research subject safety/ ethics ◦ IRB approval for all changes made to protocol  Protocol deviation management

The PI must ensure:  Data collection, including source documentation and integrity and investigator data management process  Regulatory documents are present and organized  Control to ensure security and confidentiality of the records  Delegation of Authority and training records (to verify record/data accuracy )  Documentation of training for research team

 Internal quality assurance and quality control  Monitoring process  Internal assessment capabilities

 May see more request for documentation of PI involvement ◦ Training records ◦ Meetings documentation ◦ correspondence  Audits will not review every subject record ◦ Research team will be responsible for finding additional issues and correcting based on instructions for the auditors

QUESTIONS